These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 8703249)
1. The modulatory effect of antigen- and PAF-induced asthmatic reaction by aerosol administration of OKY-046 in guinea pigs. Tsai JJ; Tsai CF; Wang SR; Han SH Asian Pac J Allergy Immunol; 1995 Dec; 13(2):87-93. PubMed ID: 8703249 [TBL] [Abstract][Full Text] [Related]
2. Suppressive effects of Y-24180, a receptor antagonist to platelet activating factor (PAF), on antigen-induced asthmatic responses in guinea pigs. Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Matsuura M; Kawakami Y; Terasawa M Inflamm Res; 1997 Apr; 46(4):147-53. PubMed ID: 9137994 [TBL] [Abstract][Full Text] [Related]
3. [Effect of thromboxane A2 synthetase inhibitor (OKY-046) on leukotriene C4-induced airway hyperresponsiveness in guinea pigs]. Tsukagoshi H; Yodonawa S; Kurosawa M Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jun; 31(6):707-11. PubMed ID: 8345703 [TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effects of OKY-046.HCl, a selective thromboxane (TX) A2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness in guinea pigs]. Takehana Y; Hamano S; Kikuchi S; Kusama H; Komatsu H; Okegawa T; Ikeda S Nihon Yakurigaku Zasshi; 1990 Jan; 95(1):21-30. PubMed ID: 2303203 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory action of OKY-O46.HCl, a specific TXA2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness of guinea pigs: role of TXA2 in development of PAF-induced nonspecific airway hyperresponsiveness. Takehana Y; Hamano S; Kikuchi S; Komatsu H; Okegawa T; Ikeda S Jpn J Pharmacol; 1990 Apr; 52(4):621-30. PubMed ID: 2160552 [TBL] [Abstract][Full Text] [Related]
6. The mechanism of airway hyperresponsiveness following immediate asthmatic response in ovalbumin-sensitized guinea-pigs. Minoguchi K; Adachi M; Kobayashi T; Takahashi T J Lipid Mediat; 1992; 5(2):169-72. PubMed ID: 1525359 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies of platelet-activating factor (PAF)-induced augmentation of response to histamine in guinea-pigs. Sakurai T; Yamaguchi S; Iwama T; Nagai H Prostaglandins Leukot Essent Fatty Acids; 1994 Aug; 51(2):95-9. PubMed ID: 7972272 [TBL] [Abstract][Full Text] [Related]
8. Effect of OKY-046, a new thromboxane A2 synthetase inhibitor, on experimental asthma in guinea pigs. Nagai H; Yakuo I; Togawa M; Arimura A; Matsuura N; Koda A; Hamano S; Ujiie A; Nakazawa M Prostaglandins Leukot Med; 1987 Dec; 30(2-3):111-21. PubMed ID: 2447593 [TBL] [Abstract][Full Text] [Related]
9. Effect of a thromboxane A2 synthetase inhibitor (OKY-046.HCl) on airway hyperresponsiveness in guinea pigs. Komatsu H; Takehana Y; Kikuchi S; Kojima M; Hamano S; Kusama H; Okegawa T; Ikeda S Eur J Pharmacol; 1990 Aug; 184(1):87-95. PubMed ID: 2170151 [TBL] [Abstract][Full Text] [Related]
10. [Effect of Asthremedin on bronchial hyperresponsiveness (BHR) to histamine induced by intravenous administration of platelet activating factor (PAF) in guinea pigs]. Tsukagoshi H; Kurosawa M Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Mar; 31(3):310-6. PubMed ID: 8391092 [TBL] [Abstract][Full Text] [Related]
11. Effect of NZ-107 on late-phase airway responses and airway hyperreactivity in guinea pigs. Iwama T; Shikada K; Yamamoto A; Sakashita M; Hibi M; Tanaka S Eur J Pharmacol; 1991 Jul; 199(3):271-8. PubMed ID: 1915580 [TBL] [Abstract][Full Text] [Related]
12. [Platelet activating factor (PAF)-induced late asthmatic response in sensitized but not in non-sensitized guinea pigs]. Arima M; Yukawa T; Terashi Y; Sagara H; Makino S Arerugi; 1992 May; 41(5):607-14. PubMed ID: 1520069 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of a thromboxane A2 synthetase inhibitor OKY-046 on bronchial hyperresponsiveness to histamine, but not on airway wall thickening, induced by intravenous administration of leukotriene C4 in guinea-pigs. Kurosawa M; Tsukagoshi H Pulm Pharmacol; 1993 Dec; 6(4):247-53. PubMed ID: 8148578 [TBL] [Abstract][Full Text] [Related]
14. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. Tohda Y; Muraki M; Kubo H; Itoh M; Haraguchi R; Nakajima S; Fukuoka M Respiration; 2001; 68(1):73-7. PubMed ID: 11223734 [TBL] [Abstract][Full Text] [Related]
15. The effect of the selective PAF antagonist CIS-19 on PAF- and antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity in guinea-pigs. Lin CH; Ko FN; Ishii H; Ishikawa T; Chen IS; Teng CM; Kuo HP Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):210-6. PubMed ID: 9050014 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of OKY-046 on spasmogen-induced bronchoconstrictions in sensitized and non-sensitized guinea pigs. Nambu F; Motoishi M; Omawari N; Okegawa T; Kawasaki A; Ikeda S Jpn J Pharmacol; 1990 Feb; 52(2):307-17. PubMed ID: 2313938 [TBL] [Abstract][Full Text] [Related]
17. Role of nitric oxide in the development and partial reversal of allergen-induced airway hyperreactivity in conscious, unrestrained guinea-pigs. Schuiling M; Zuidhof AB; Bonouvrie MA; Venema N; Zaagsma J; Meurs H Br J Pharmacol; 1998 Apr; 123(7):1450-6. PubMed ID: 9579742 [TBL] [Abstract][Full Text] [Related]
18. Fluticasone propionate and pentamidine isethionate reduce airway hyperreactivity, pulmonary eosinophilia and pulmonary dendritic cell response in a guinea pig model of asthma. Lawrence TE; Millecchia LL; Fedan JS J Pharmacol Exp Ther; 1998 Jan; 284(1):222-7. PubMed ID: 9435182 [TBL] [Abstract][Full Text] [Related]